• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症中的氧化应激

Oxidative stress in Systemic Sclerosis.

作者信息

Simonini G, Cerinic M M, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M

机构信息

Department of Pediatrics, University of Florence, Italy.

出版信息

Mol Cell Biochem. 1999 Jun;196(1-2):85-91.

PMID:10448906
Abstract

In 63 patients affected by Systemic Sclerosis (SSc) (limited subset: 40; diffuse subset: 23; early: 30; advanced: 33) the peroxidation product diene-conjugates (DC) and antibodies against oxidised low density lipoproteins (Ab oxLDL) were tested in serum by a spectrophotometer (absorbance 234 mn) and by a standard ELISA respectively. The data were compared with those obtained by 21 healthy subjects. DC was significantly higher in patients (73.3 +/- 37.2 microM/l; p < 0.0001) than in controls (48.4 +/- 16.7) as well as in the limited (80 +/- 48.8; p < 0.05) than in the diffuse subset (64.5 +/- 36.4); and in early (84.1 +/- 31.4; p < 0.05) than in advanced stage of the disease (67.9 +/- 42.5). The levels of Ab oxLDL were significantly higher in SSc patients (309.5 +/- 367.2 mU/ml; p < 0.0001) in all its subsets (limited: 351.9 +/- 351.1, p < 0.0001; diffuse: 207.7 +/- 316.1, p < 0.05; early: 428.9 +/- 417.1, p < 0.001; advanced: 302.7 +/- 89.9, p < 0.0001) than in controls (89.3 +/- 29.1). These antibodies levels were higher in limited subset than in diffuse (p < 0.05) and in early SSc than in advanced SSc (p < 0.05). The highest values of parameters of oxidative stress are found in the early stages, when the episodes of reperfusion after ischemic episodes (Raynaud's phenomenon) are very frequent. Moreover, the damage is higher in the early stages of SSc, with intact microvessels, than in late stages, when microvessels are very reduced in number, destroyed by the worsening of the disease. These data show that the respiratory burst deduced by the lipoperoxidation is higher in SSc than in controls, and may be an important pathogenetic factors involved in tissue changes in SSc.

摘要

在63例系统性硬化症(SSc)患者中(局限性亚型:40例;弥漫性亚型:23例;早期:30例;晚期:33例),分别用分光光度计(在234nm处吸光度)和标准酶联免疫吸附测定法(ELISA)检测血清中的过氧化产物二烯共轭物(DC)和抗氧化型低密度脂蛋白抗体(Ab oxLDL)。将这些数据与21名健康受试者的数据进行比较。患者的DC(73.3±37.2μM/L;p<0.0001)显著高于对照组(48.4±16.7),局限性亚型患者的DC(80±48.8;p<0.05)高于弥漫性亚型患者(64.5±36.4);疾病早期患者的DC(84.1±31.4;p<0.05)高于晚期患者(67.9±42.5)。SSc患者各亚型的Ab oxLDL水平(309.5±367.2mU/ml;p<0.0001)均显著高于对照组(89.3±29.1)(局限性亚型:351.9±351.1,p<0.0001;弥漫性亚型:207.7±316.1,p<0.05;早期:428.9±417.1,p<0.001;晚期:302.7±89.9,p<0.0001)。这些抗体水平在局限性亚型中高于弥漫性亚型(p<0.05),在SSc早期高于晚期(p<0.05)。氧化应激参数的最高值出现在疾病早期,此时缺血发作(雷诺现象)后的再灌注发作非常频繁。此外,在SSc早期微血管完整时的损伤程度高于晚期,晚期微血管数量非常减少,因疾病恶化而被破坏。这些数据表明,SSc患者中由脂质过氧化推导的呼吸爆发高于对照组,可能是参与SSc组织变化的重要致病因素。

相似文献

1
Oxidative stress in Systemic Sclerosis.系统性硬化症中的氧化应激
Mol Cell Biochem. 1999 Jun;196(1-2):85-91.
2
Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis.
J Rheumatol. 2001 Jan;28(1):198-203.
3
Antibodies against oxidized low-density lipoproteins in systemic sclerosis.系统性硬化症中抗氧化型低密度脂蛋白抗体
Rheumatology (Oxford). 2001 Apr;40(4):401-5. doi: 10.1093/rheumatology/40.4.401.
4
OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.系统性红斑狼疮、系统性硬化症和抗磷脂综合征患者体内的氧化型低密度脂蛋白/β2糖蛋白I复合物及自身抗体:对血管受累的致病意义
Ann N Y Acad Sci. 2005 Jun;1051:313-22. doi: 10.1196/annals.1361.073.
5
Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury.系统性硬化症中红细胞膜流动性、脂质成分及脂质过氧化异常:自由基介导损伤的证据
Arthritis Rheum. 2000 Apr;43(4):894-900. doi: 10.1002/1529-0131(200004)43:4<894::AID-ANR22>3.0.CO;2-4.
6
Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.C 反应蛋白与系统性硬化症高疾病活动度的相关性:来自加拿大硬皮病研究组的研究结果。
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.
7
Cutaneous and serologic subsets of systemic sclerosis.系统性硬化症的皮肤和血清学亚组
J Rheumatol. 1991 Dec;18(12):1826-32.
8
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.继发于系统性硬化症的雷诺现象患者接受伊洛前列素治疗后的抗氧化状态。
Clin Rheumatol. 2007 Sep;26(9):1517-21. doi: 10.1007/s10067-007-0613-2. Epub 2007 Mar 31.
9
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.系统性硬化症中的甲襞微血管镜检查模式与血清自身抗体
Rheumatology (Oxford). 2004 Jun;43(6):719-26. doi: 10.1093/rheumatology/keh156. Epub 2004 Mar 16.
10
Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.系统性硬化症的性别与诊断时间:对加拿大硬皮病研究组登记处1129例患者的最新分析
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-10-4. Epub 2013 Oct 11.

引用本文的文献

1
Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology.酶联免疫吸附测定技术在三个十年内对氧化型低密度脂蛋白抗体(oLAb)临床相关性的概述
Antioxidants (Basel). 2024 Dec 19;13(12):1560. doi: 10.3390/antiox13121560.
2
The Potential of Twendee X as a Safe Antioxidant Treatment for Systemic Sclerosis.Twendee X作为系统性硬化症安全抗氧化治疗方法的潜力。
Int J Mol Sci. 2024 Mar 6;25(5):3064. doi: 10.3390/ijms25053064.
3
Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.

本文引用的文献

1
Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma.金属催化氧化反应在硬皮病早期发病机制中的作用。
Curr Opin Rheumatol. 1997 Nov;9(6):538-43. doi: 10.1097/00002281-199711000-00010.
2
Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.低密度脂蛋白与氧化型低密度脂蛋白:它们在动脉粥样硬化发展中的作用。
Pharmacol Ther. 1997;74(1):55-72. doi: 10.1016/s0163-7258(96)00202-1.
3
Modified low density lipoprotein is a potent stimulus for smooth muscle cell outgrowth from rat aortic explant in vitro.
在生命线人群中,自我报告的系统性硬化症相关症状在患有雷诺现象的受试者中更为普遍:关注肺部并发症。
Diagnostics (Basel). 2023 Jun 25;13(13):2160. doi: 10.3390/diagnostics13132160.
4
Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies.地方性落叶型天疱疮患者及抗桥粒芯蛋白1抗体阳性健康受试者的氧化应激
An Bras Dermatol. 2018 Mar;93(2):212-215. doi: 10.1590/abd1806-4841.20186211.
5
Cardiorheumatology: cardiac involvement in systemic rheumatic disease.心脏风湿病学:系统性风湿性疾病中的心脏受累情况。
Nat Rev Cardiol. 2015 Mar;12(3):168-76. doi: 10.1038/nrcardio.2014.206. Epub 2014 Dec 23.
6
The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse.天然有机硫化合物二丙基四硫预防 HOCl 诱导的小鼠系统性硬化症。
Arthritis Res Ther. 2013 Oct 28;15(5):R167. doi: 10.1186/ar4351.
7
Animal models of scleroderma: current state and recent development.硬皮病的动物模型:现状和最新进展。
Curr Rheumatol Rep. 2013 Dec;15(12):382. doi: 10.1007/s11926-013-0382-7.
8
Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis.作为晚期糖基化终末产物积累和累积代谢应激标志物的皮肤自发荧光,在系统性硬化症患者中并未增加。
Int J Rheumatol. 2011;2011:417813. doi: 10.1155/2011/417813. Epub 2011 Sep 29.
9
Apoptosis modulation as a promising target for treatment of systemic sclerosis.细胞凋亡调控作为系统性硬化症治疗的一个有前景的靶点。
Int J Rheumatol. 2011;2011:495792. doi: 10.1155/2011/495792. Epub 2011 Sep 6.
10
Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.系统性硬化症中的动脉粥样硬化:一项系统评价和荟萃分析。
Arthritis Rheum. 2011 Jul;63(7):2078-90. doi: 10.1002/art.30380.
Atherosclerosis. 1997 Feb 28;129(1):1-7. doi: 10.1016/s0021-9150(96)06000-5.
4
Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis.硬皮病自身抗原通过金属催化氧化反应被独特地片段化:对发病机制的影响。
J Exp Med. 1997 Jan 6;185(1):71-9. doi: 10.1084/jem.185.1.71.
5
Basic research in antioxidant inhibition of steps in atherogenesis.
J Cardiovasc Risk. 1996 Aug;3(4):352-7. doi: 10.1177/174182679600300403.
6
Elevated plasma superoxide dismutase activity in patients with systemic sclerosis.
J Dermatol Sci. 1996 Mar;11(3):196-201. doi: 10.1016/0923-1811(95)00441-6.
7
Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis.系统性硬化症患者的微量营养素抗氧化剂膳食摄入量与血液水平的关系
J Rheumatol. 1996 Apr;23(4):650-3.
8
Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.
Arthritis Rheum. 1996 Jul;39(7):1146-50. doi: 10.1002/art.1780390711.
9
Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells.低密度脂蛋白的氧化修饰程度决定了对人冠状动脉细胞的细胞毒性程度。
Heart. 1996 Jan;75(1):11-6. doi: 10.1136/hrt.75.1.11.
10
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.冠心病患者及正常健康志愿者体内的抗氧化型低密度脂蛋白抗体
Int J Clin Lab Res. 1993;23(2):95-101. doi: 10.1007/BF02592290.